Major Depressive Disorder
Item
diagnosis of major depressive disorder as defined by the diagnostic and statistical manual of mental disorders, 4th edition-text revision (dsm-iv-tr) and the mini international neuropsychiatric interview (mini) criteria.
boolean
C1269683 (UMLS CUI [1])
Outpatients | Hospitalization Duration Unwilling
Item
outpatients unwilling to be hospitalized a total of 6 nights and 8 days.
boolean
C0029921 (UMLS CUI [1])
C0019993 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Hamilton Depression Rating Scale 17 Item Questionnaire
Item
total score of less than 21 (<21) on the 17-item hamilton depression rating scale (ham-d) at visit 1 (day -7) or visit 5 (day -1).
boolean
C3639712 (UMLS CUI [1])
Depressive episode | Psychotic symptom | Feature Catatonic | Seasonal Affective Disorder | Depression, Postpartum | Depressive episode Secondary to Disease General
Item
patients whose current depressive episode is diagnosed with psychotic features, catatonic features, seasonal pattern or post-partum onset or is secondary to a general medical disorder.
boolean
C0349217 (UMLS CUI [1])
C0871189 (UMLS CUI [2])
C2348519 (UMLS CUI [3,1])
C0007398 (UMLS CUI [3,2])
C0085159 (UMLS CUI [4])
C0221074 (UMLS CUI [5])
C0349217 (UMLS CUI [6,1])
C0175668 (UMLS CUI [6,2])
C0012634 (UMLS CUI [6,3])
C0205246 (UMLS CUI [6,4])
Substance Dependence | Substance Use Disorders | Nicotine Dependence | Caffeine dependence
Item
patients with alcohol dependence or abuse or substance dependence or abuse in the past 12 months according to the mini, except nicotine or caffeine dependence.
boolean
C0038580 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0028043 (UMLS CUI [3])
C1386553 (UMLS CUI [4])
Antipsychotic Agents | Fluoxetine | Monoamine Oxidase Inhibitors | Antidepressive Agents | Anti-Anxiety Agents | Hypnotics and Sedatives | Mood Stabilizer | Lithium | Anticonvulsants
Item
patients who have used the following prior to entry into segment b: any antipsychotic within 3 months; fluoxetine within 1 month; any monoamine oxidase inhibitor (maoi) within 2 weeks; any other antidepressant, anxiolytic, sedative-hypnotic, or mood-stabilizer (lithium, anticonvulsants) within 7 days except permitted concomitant medications
boolean
C0040615 (UMLS CUI [1])
C0016365 (UMLS CUI [2])
C0026457 (UMLS CUI [3])
C0003289 (UMLS CUI [4])
C0040616 (UMLS CUI [5])
C0020592 (UMLS CUI [6])
C2917435 (UMLS CUI [7])
C0023870 (UMLS CUI [8])
C0003286 (UMLS CUI [9])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])